Kyntra Bio, Inc. (KYNB)
7.03
-0.07
(-0.99%)
USD |
NASDAQ |
Sep 18, 15:40
Kyntra Bio Total Return Level : 7.10 for Sept. 17, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 17, 2026 | 7.10 |
| September 16, 2026 | 7.61 |
| September 15, 2026 | 7.77 |
| September 14, 2026 | 8.03 |
| September 11, 2026 | 7.97 |
| September 10, 2026 | 7.975 |
| September 09, 2026 | 8.04 |
| September 08, 2026 | 8.22 |
| September 04, 2026 | 8.55 |
| September 03, 2026 | 8.49 |
| September 02, 2026 | 8.53 |
| September 01, 2026 | 7.95 |
| August 31, 2026 | 7.78 |
| August 28, 2026 | 8.02 |
| August 27, 2026 | 8.00 |
| August 26, 2026 | 8.105 |
| August 25, 2026 | 8.10 |
| August 24, 2026 | 7.98 |
| August 21, 2026 | 7.52 |
| August 20, 2026 | 7.32 |
| August 19, 2026 | 7.15 |
| August 18, 2026 | 7.01 |
| August 17, 2026 | 6.81 |
| August 14, 2026 | 7.05 |
| August 13, 2026 | 7.04 |
| Date | Value |
|---|---|
| August 12, 2026 | 7.10 |
| August 11, 2026 | 7.07 |
| August 10, 2026 | 6.97 |
| August 07, 2026 | 7.27 |
| August 06, 2026 | 6.980 |
| August 05, 2026 | 6.99 |
| August 04, 2026 | 6.92 |
| August 03, 2026 | 6.76 |
| July 31, 2026 | 6.73 |
| July 30, 2026 | 6.79 |
| July 29, 2026 | 6.78 |
| July 28, 2026 | 6.975 |
| July 27, 2026 | 7.05 |
| July 24, 2026 | 7.03 |
| July 23, 2026 | 7.07 |
| July 22, 2026 | 7.215 |
| July 21, 2026 | 7.300 |
| July 20, 2026 | 7.04 |
| July 17, 2026 | 7.23 |
| July 16, 2026 | 7.39 |
| July 15, 2026 | 7.21 |
| July 14, 2026 | 7.32 |
| July 13, 2026 | 7.345 |
| July 10, 2026 | 7.605 |
| July 09, 2026 | 7.32 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Vericel Corp. | 40.03 |
| Capricor Therapeutics, Inc. | 9.42 |
| ARS Pharmaceuticals, Inc. | 4.15 |
| ACADIA Pharmaceuticals, Inc. | 27.45 |
| Alnylam Pharmaceuticals, Inc. | 245.51 |